BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 288971)

  • 21. Treatment of acute lymphoblastic leukaemia.
    Jacquillat C; Weil M; Gemon-Auclerc MF; Boiran M; Bernard J
    Haematologia (Budap); 1976; 10(1):57-65. PubMed ID: 1070468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
    Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current methods of treatment of acute lymphoblastic leukemia in children].
    Armata J; Bogusllawska-Jaworska J
    Pediatr Pol; 1975 Mar; 50(3):383-8. PubMed ID: 1054477
    [No Abstract]   [Full Text] [Related]  

  • 24. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
    Maiakova SA; Makhonova LA
    Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our recent therapeutic experiences in acute leukemia].
    Quattrin N; Montuori R; Di Girolamo R; Cimino R
    Minerva Med; 1975 Jul; 66(51):2538-45. PubMed ID: 1057050
    [No Abstract]   [Full Text] [Related]  

  • 26. Reinduction therapy for adult acute leukemia with adriamycin, vincristine, and prednisone: a Southwest Oncology Group study.
    Elias L; Shaw MT; Raab SO
    Cancer Treat Rep; 1979 Aug; 63(8):1413-5. PubMed ID: 289442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of acute leukemias].
    Brilliant MD
    Ter Arkh; 1973 Sep; 45(9):72-85. PubMed ID: 4585646
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).
    Jacquillat C; Weil M; Gemon MF; Auclerc G; Loisel JP; Delobel J; Flandrin G; Schaison G; Izrael V; Bussel A; Dresch C; Weisgerber C; Rain D; Tanzer J; Najean Y; Seligmann M; Boiron M; Bernard J
    Cancer Res; 1973 Dec; 33(12):3278-84. PubMed ID: 4519131
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination therapy involving L-asparaginase in acute leukemia.
    Tan C; Haghbin M; Gee T; Clarkson B; Murphy ML
    Bibl Haematol; 1973; 39():1074-84. PubMed ID: 4521513
    [No Abstract]   [Full Text] [Related]  

  • 30. [L-Asparaginase in the treatment of acute leukemia].
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
    Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
    [No Abstract]   [Full Text] [Related]  

  • 31. Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Hayat M; de Vassal F; Jasmin C; Rosenfeld C; Pouillart P
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):216-24. PubMed ID: 4997294
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
    Castel V; Verdeguer A; Ferris J; Esquembre C
    An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Present-day treatment of acute leukemia in children].
    Rumiantsev AG
    Pediatriia; 1980; (5):57-62. PubMed ID: 6930631
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy?].
    Pastore G; Cordero di Montezemolo L; Boschis MP; Ghibaudo P; Saracco P; Miniero R; Madon E; Forni M; Saitta M
    Haematologica; 1985; 70(4):313-8. PubMed ID: 3935529
    [No Abstract]   [Full Text] [Related]  

  • 36. [Induction and interval treatment of leukemias in children and juveniles].
    Oehme J; Meyer-Beeck D
    Dtsch Med Wochenschr; 1969 Sep; 94(39):1993-6. PubMed ID: 5352272
    [No Abstract]   [Full Text] [Related]  

  • 37. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
    Freeman AI
    Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
    Aur RJ; Simone JV; Pratt CB
    Cancer; 1971 Jun; 27(6):1332-6. PubMed ID: 5282619
    [No Abstract]   [Full Text] [Related]  

  • 39. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in the treatment of juvenile leukemias].
    Gadner H; Krepler P; Kundi M; Mutz I; Pichler E; Schmidmeier W; Tulzer W; Urban C
    Wien Med Wochenschr; 1982 Jul; 132(13-14):313-8. PubMed ID: 6958132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.